Literature DB >> 10629398

Venous thrombosis: prevalence and interaction of risk factors.

F R Rosendaal1.   

Abstract

The key to understanding why certain individuals develop deep vein thrombosis at varying times, despite similar risk factors being present, is the realization of the importance of gene-gene and gene-environment interactions between risk factors. The discovery of factor V Leiden and several other coagulation abnormalities, which are now known to be common in the general population, has revolutionized the way in which the aetiology of venous thrombosis is viewed. On the basis of current knowledge, time-dependent models taking account of various forms of interaction have been developed. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629398     DOI: 10.1159/000054106

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  9 in total

1.  Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk.

Authors:  Jihye Kim; Peter Kraft; Kaitlin A Hagan; Laura B Harrington; Sara Lindstroem; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2018-03-08       Impact factor: 2.135

2.  Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Authors:  N A Limdi; T M Beasley; D B Allison; C A Rivers; R T Acton
Journal:  Blood Cells Mol Dis       Date:  2006-08-02       Impact factor: 3.039

3.  Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.

Authors:  Adriano de Paula Sabino; Daniela Amorim Melgaço Guimarães; Daniel Dias Ribeiro; Sabrina Guimarães Paiva; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  J Thromb Thrombolysis       Date:  2007-03-31       Impact factor: 2.300

Review 4.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

Review 5.  Lactoferrin: from the structure to the functional orchestration of iron homeostasis.

Authors:  Giusi Ianiro; Luigi Rosa; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci; Antimo Cutone
Journal:  Biometals       Date:  2022-10-10       Impact factor: 3.378

6.  Flap complications and thrombophilia: an evidence-based model and cost analysis for preoperative screening.

Authors:  Kendra G Bowman; Matthew J Carty
Journal:  Eplasty       Date:  2011-07-08

7.  Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study.

Authors:  Sverre C Christiansen; Inger Anne Naess; Suzanne C Cannegieter; Jens Hammerstrøm; Frits R Rosendaal; Pieter H Reitsma
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

8.  The 3' end prothrombin gene variants in serbian patients with idiopathic thrombophilia.

Authors:  M Aradjanski; V Djordjevic; I Pruner; B Tomic; M Gvozdenov; M Kovac; D Radojkovic
Journal:  Balkan J Med Genet       Date:  2015-04-10       Impact factor: 0.519

Review 9.  Inherited thrombophilia: key points for genetic counseling.

Authors:  Elizabeth Varga
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.